Jacon Philippe 4/A
4/A · CEPHEID · Filed May 6, 2013
Insider Transaction Report
Form 4/AAmended
CEPHEIDCPHD
Jacon Philippe
EVP, Emerging Markets
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-05-03+52,500→ 52,500 totalExercise: $38.15Exp: 2019-11-03→ Common Stock (52,500 underlying)
Footnotes (2)
- [F1]As the result of an administrative error, the Form 4 previously filed with the Securities and Exchange Commission on May 1, 2013 did not properly reflect the terms of the option that are required by the terms of the Issuer's French sub-plan. This amended Form 4 reflects the following changes: (a) the grant date was incorrectly identified as April 29, 2013 on the original Form 4 and is corrected to May 3, 2013, (b) the exercise price of the option was incorrectly identified as $38.66 on the original Form 4, which was the closing price of the Issuer's common stock on April 29, 2013, and is corrected to $38.15, which was the closing price of the Issuer's common stock on May 3, 2013 and (c) the expiration date was incorrectly identified as April 29, 2020 on the original Form 4 and is corrected to November 3, 2019.
- [F2]25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.083% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.